Announced Fri, 4 Sept · 14:59 IST
34th AGM on Sep 29, 2026; seeks nod for Rs 120 Cr Ipca Labs related party deals
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.9%1-day move
₹55.65
prior close
₹55.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.5+0.0+2.5+2.5+1.9+1.9+7.0+9.6+7.3+3.3————
Up moveDown movePending
AI summary
Krebs Biochemicals sent the 34th AGM notice for Sep 29, 2026 via video conferencing. Agenda covers adoption of FY26 financials, re-appointment of two directors, related party deals with promoter Ipca Labs up to Rs 120 Crore annually, and cost auditor pay ratification. E-voting runs Sep 25-28. FY26 total income fell to Rs 25.76 Cr (from Rs 44.02 Cr); net loss narrowed to Rs 16.93 Cr (from Rs 26.94 Cr). Net worth remains deeply negative.
Likely market impact
Loss-making firm in its 5th straight year of losses; seeks Rs 120 Cr related party deal approval with promoter Ipca Labs. Net worth fully eroded.